The company
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
The funding
Polares Medical, based in Lausanne, Switzerland, announced $50M in Series C financing on March 6, 2026.
Participants include DC Global Ventures, Lumination Partners.